MAPK/ERK pathway
From Proteopedia
(Difference between revisions)
Line 19: | Line 19: | ||
==[[Rho guanine nucleotide exchange factor]]== | ==[[Rho guanine nucleotide exchange factor]]== | ||
- | ==Ras | + | ==Ras activation== |
[[GTPase KRas]] | [[GTPase KRas]] | ||
Revision as of 13:38, 17 February 2022
|
References
- ↑ Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, Davies H, Cox C, Brignell G, Stephens P, Futreal PA, Wooster R, Stratton MR, Weber BL. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002 Dec 1;62(23):6997-7000. PMID:12460918
- ↑ Antony R, Emery CM, Sawyer AM, Garraway LA. C-RAF mutations confer resistance to RAF inhibitors. Cancer Res. 2013 Aug 1;73(15):4840-51. doi: 10.1158/0008-5472.CAN-12-4089. Epub, 2013 Jun 4. PMID:23737487 doi:http://dx.doi.org/10.1158/0008-5472.CAN-12-4089